A blockade of Epo signaling destroyed the xenografts by inhibition of tumor growth, angiogenesis and survival through disruption of the harmonized hemoprotein syntheses in the tumor cells, leading to the loss of protection against O2, NO or ROS toxicity. The gene discussed is EPO; the disease is neoplasm.